Skip to main content
. 2023 Apr 19;9(5):e15211. doi: 10.1016/j.heliyon.2023.e15211

Fig. 3.

Fig. 3

Comparison of the neutralizing capacity of serum from individuals vaccinated with different SARS-CoV-2 vaccine. A Pre-incubation of the pseudovirus VSVΔg expressing the protein SPIKE and the fluorescent eGFP protein, with serial dilutions of serum from individuals vaccinated with Sputnik V (a–d), AstraZeneca (e–h) and Sinopharm (i–l) resulted in a clear inhibition of the infection of the Vero CCL81 cells. Bar: 20 μm B. The neutralization capacity of serum samples from individuals that received different vaccines, or non-vaccinated individuals were measured by flow cytometry and the eGFP fluorescence was interpreted as a percentage of infection. Each dot represents the median value in each group of vaccinated * Naïve: non-vaccinated, non-infected with SARS-CoV-2 individuals.